Black Diamond Therapeutics, Inc. BDTX

Set alert

Price alert · BDTX

All alert types
1.81 USD +0.05 +3.14%

As of Nov 3, 2:01 PM ET

Bid
1.80 × 1
Ask
1.81 × 1
1.76 Day range 1.85
1.60 52-week range 4.94
YTD
-25.72%
1 year
-54.30%
Open
1.76
Prev close
1.75
Mkt cap
103.70M
Vol
175.94K
Avg vol
685.00K
EPS
-0.75
P/E
0.00
Div yield
0.00%
More statistics
Low
1.76
High
1.85
Forward P/E
-1.80
Beta
2.52
Short ratio
11.67
Inst. own
98.71%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
2.79
200-d avg
4.63
1y target
14.50

1D chart

Chart tools
Interval

Signals (40)
NameTimeAgo
RSI: Oversold3:29 PM22 hours ago
MACD: Sell Signal3:16 PM22 hours ago
MACD: Buy Signal2:52 PM23 hours ago
MACD: Sell Signal2:48 PM23 hours ago
SMA: Bearish2:47 PM23 hours ago
SMA: Bearish2:47 PM23 hours ago
MACD: Buy Signal2:41 PM23 hours ago
MACD: Sell Signal2:34 PM23 hours ago
RSI: Oversold2:34 PM23 hours ago
MACD: Buy Signal2:11 PM23 hours ago
MACD: Sell Signal2:02 PM1 day ago
RSI: Oversold2:02 PM1 day ago
MACD: Buy Signal1:56 PM1 day ago
RSI: Oversold1:52 PM1 day ago
MACD: Sell Signal1:41 PM1 day ago
MACD: Buy Signal1:36 PM1 day ago
MACD: Sell Signal1:23 PM1 day ago
RSI: Oversold1:23 PM1 day ago
MACD: Buy Signal12:52 PM1 day ago
MACD: Sell Signal12:46 PM1 day ago

Newest 20 of 40.

Analyst view

Price target (mean) 14.50 +703.3% upside
Target (low)
9.00
Target (mean)
14.50
Target (high)
20.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BDTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.31167-0.36 – -0.21-0.34+8.3%00.0%6
Next quarter-0.33-0.44 – -0.20-0.35+5.7%00.0%4
Current year-1.27-1.34 – -1.04-1.88+32.5%00.0%6
Next year-1.25-1.93 – -0.68-1.27+1.2%00.0%6

Upgrades and downgrades

The latest rating changes

BDTX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 8, 2024WedbushReiteratedOutperformOutperform
Sep 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 23, 2024Piper SandlerMaintainedOverweightOverweight
Sep 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 10, 2024WedbushReiteratedOutperformOutperform
Sep 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2024WedbushReiteratedOutperformOutperform
Jul 31, 2024Raymond JamesInitiated—Outperform
Jul 3, 2024Piper SandlerMaintainedOverweightOverweight
Jun 7, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 8, 2024WedbushMaintainedOutperformOutperform
Mar 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 13, 2024WedbushReiteratedOutperformOutperform
Nov 22, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 12, 2023WedbushReiteratedOutperformOutperform
Jul 14, 2023Piper SandlerInitiated—Overweight
Jun 30, 2023StifelUpgradeHoldBuy
Jun 28, 2023HC Wainwright & Co.UpgradeNeutralBuy
Jun 27, 2023StifelReiteratedHoldHold
Jun 27, 2023WedbushUpgradeNeutralOutperform
May 10, 2023WedbushReiterated—Neutral
Mar 29, 2022WedbushDowngradeOutperformNeutral
Mar 22, 2022HC Wainwright & Co.DowngradeBuyNeutral
Mar 18, 2022StifelMaintained—Hold
Sep 30, 2021StifelInitiated—Hold
Jan 7, 2021WedbushInitiated—Outperform
Nov 24, 2020BerenbergInitiated—Buy